What is the recommended treatment for shingles (herpes zoster) in otherwise healthy adults?

Treatment of Shingles (Herpes Zoster) in Otherwise Healthy Adults

Start oral antiviral therapy with acyclovir 800 mg five times daily, valacyclovir 1 g three times daily, or famciclovir 500 mg three times daily for 7–10 days, ideally within 72 hours of rash onset, to shorten disease duration, reduce acute pain, and lower the risk of post-herpetic neuralgia. 1

First-Line Antiviral Selection

All three oral antivirals are considered equally effective and well-tolerated; your choice should be based primarily on dosing convenience: 1

• Acyclovir: 800 mg orally five times daily for 7–10 days 1
• Valacyclovir: 1 g orally three times daily for 7 days (superior pharmacokinetics and more convenient dosing make this a preferred option) 2
• Famciclovir: 500 mg orally three times daily for 7 days (also preferred due to convenient dosing) 2

Valacyclovir and famciclovir demonstrate superior pain reduction compared to acyclovir, with valacyclovir showing a 36% risk reduction in pain at 21–30 days (number needed to treat = 3) and famciclovir showing a 46% reduction at 28–30 days. 2 Despite this, all three agents are FDA-approved and guideline-endorsed. 1, 3

Timing of Treatment Initiation

• Within 72 hours of rash onset is the standard window for maximum benefit—this timing shortens disease duration, reduces acute pain, and lowers post-herpetic neuralgia risk. 1
• After 72 hours, antivirals still accelerate cutaneous healing and reduce viral shedding compared to no therapy, so treatment should not be withheld. 1
• Continue therapy for the full 7–10 day course until all lesions have completely scabbed over. 1

Urgent Indications for Antiviral Treatment

Certain populations require immediate antiviral therapy regardless of timing: 1

• Age ≥50 years: This group has the highest risk of developing post-herpetic neuralgia and should always receive prompt treatment. 1
• Immunocompromised patients of any age (HIV infection, organ transplant recipients, those on immunosuppressive therapy) require urgent antiviral therapy. 1, 4
• Severe disease: Extensive rash, disseminated infection, or visceral involvement demands immediate treatment. 1
• Herpes zoster ophthalmicus or head/neck involvement: These cases carry high complication risk and require urgent systemic antivirals. 5

Pain Management

Pain control is a critical component of shingles treatment: 5

• Mild-to-moderate pain: Acetaminophen or NSAIDs 1
• Moderate-to-severe pain: Consider adding gabapentin, pregabalin, or tricyclic antidepressants (e.g., amitriptyline) alongside antivirals 6, 5
• Opioid analgesics may be necessary for severe acute pain 6
• Loose-fitting cotton clothing minimizes irritation 1

Treatment Pitfalls to Avoid

• Never use topical acyclovir—it is substantially less effective than oral systemic therapy and should not be employed for herpes zoster. 1
• Never use abbreviated 1–3 day courses—a full 7–10 day oral course is required for all patients. 1
• Avoid high-dose valacyclovir (≥8 g/day) in HIV-infected patients due to risk of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. 1

Monitoring and Follow-Up

• Assess treatment response within 48–72 hours of initiating antivirals, watching for signs of bacterial superinfection, dissemination, or neurologic complications. 4
• Suspect acyclovir resistance if lesions fail to improve within 7–10 days of appropriate therapy; consider switching to intravenous foscarnet 40 mg/kg every 8 hours and obtain viral culture with susceptibility testing. 1
• Schedule a follow-up visit within 1–2 weeks to assess healing and screen for complications. 1

Infection Control and Patient Education

Patients remain contagious until all blisters have completely crusted: 1

• Avoid direct contact with pregnant women, newborns, and immunocompromised individuals 1
• Keep the rash clean and dry; gently wash with mild soap and water once daily 1
• Do not pick, scratch, or pop blisters 1
• Cover the rash with loose, non-adherent dressing if clothing irritates it 1
• Transmission requires direct contact with blister fluid—it does not occur via coughing or sneezing 1

Warning Signs Requiring Immediate Medical Attention

Instruct patients to seek urgent care for: 1

• Rash involving the eye, forehead, or tip of the nose (risk of vision loss)
• Severe headache, confusion, stiff neck, or altered mental status (possible CNS involvement)
• Persistent fever >101°F (38.3°C)
• Increasing redness, warmth, swelling, or pus from the rash (bacterial superinfection)
• New difficulty hearing, dizziness, or facial weakness (cranial nerve involvement)
• Worsening pain despite appropriate medication

Vaccination for Future Prevention

• Recombinant zoster vaccine (RZV/Shingrix) is the preferred formulation and requires two doses given 2–6 months apart. 7, 8
• Vaccination is recommended for adults aged ≥50 years, even after an episode of shingles, as approximately 10% of patients experience recurrence within 10 years. 8, 1
• Wait at least 2 months after the acute episode before receiving the vaccine. 1
• RZV is superior to the older live-attenuated vaccine (Zostavax) and can be used in immunocompromised patients. 8, 9